US Patent Issued to Medtronic Ireland Manufacturing UnLtd. on Jan. 13 for "Systems and methods for assessing the efficacy of neuromodulation therapy" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,060, issued on Jan. 13, was assigned to Medtronic Ireland Manufacturing UnLtd. Co. (Dublin).

"Systems and methods for assessing the efficacy of neuromodulation therapy" was invented by Michael Neidert (San Francisco), Paul Coates (Corte Madera, Calif.) and Robert L. Melder (Santa Rosa, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the...